MAX BioPharma is a start up biopharmaceutical company engaged in discovery and development of small molecules to target human disorders including non-healing bone fractures, osteoporosis, and cancer. The company is a provider in the fields of "lipidomics" and "oxysterol therapeutics" by leveraging a growing portfolio of IP that will lead to treatments for numerous indications. MAX BioPharma's first success based on small molecule lipids has contributed to the discovery of osteogenic oxysterol co...Show all

MAX BioPharma is a start up biopharmaceutical company engaged in discovery and development of small molecules to target human disorders including non-healing bone fractures, osteoporosis, and cancer. The company is a provider in the fields of "lipido...Show all

Company (Alive / Active)

All investors data 1 Investors

• National Institutes of Health